(Q48386297)

11 February 2018

title

Long-term efficacy and safety of celecoxib in Alzheimer's disease (English)

1 reference

11 February 2018

0 references

Hilkka Soininen

1

1 reference

11 February 2018

Christine West

series ordinal

2

1 reference

11 February 2018

Jeffery Robbins

series ordinal

3

1 reference

11 February 2018

Liviu Niculescu

series ordinal

4

1 reference

11 February 2018

publication date

26 October 2006

1 reference

11 February 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

11 February 2018

volume

23

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

8-21

1 reference

11 February 2018

Alzheimer Disease in the US Population

cites work

1 reference

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

Inflammatory processes in Alzheimer's disease

21 January 2018

1 reference

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

21 January 2018

1 reference

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

21 January 2018

1 reference

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

21 January 2018

1 reference

Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex

21 January 2018

1 reference

The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.

21 January 2018

1 reference

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

21 January 2018

1 reference

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

21 January 2018

1 reference

Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity

21 January 2018

1 reference

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

21 January 2018

1 reference

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway

21 January 2018

1 reference

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

21 January 2018

1 reference

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

21 January 2018

1 reference

Killing pain, not neurons

21 January 2018

1 reference

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

Autoregulation of blood pressure and thought: preliminary results of an application of brain imaging to psychosomatic medicine

21 January 2018

1 reference

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

21 January 2018

1 reference

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000096588

1 reference

11 February 2018

1 reference

11 February 2018